600222 Henan Taloph Pharmaceutical Stock
- 5.73
- +0.12+2.14%
About Henan Taloph Pharmaceutical Stock Company
The company was founded in 1993, and the company was solemnly listed on the Shanghai Stock Exchange in 1999, becoming the first listed company in the pharmaceutical industry in Henan Province. After more than 20 years of development, the company has successively taken indirect shares and controlled more than a dozen subsidiary (branch) companies, covering fields related to pharmaceutical manufacturing, drug research and development, capital operation, etc., and its main economic indicators rank among the top in the pharmaceutical industry in Henan Province. The company's main business is pharmaceutical manufacturing and drug research and development services, which specifically include the four business segments of pharmaceutical preparations, Chinese medicine tablets, drug research and development services, and pharmaceutical herbal medicine distribution. The company's main products include Shuanghuanglian oral liquid series, double gold combination, pediatric fever and cough relief oral liquid, pediatric antipyretic oral liquid, salvia, herbal drink, compound Yimu oral liquid, agastache zhengqi mixture, Wuzi Yanzong oral liquid, pediatric compound chicken neijin chewables, and taxerine tablets. Corporate honors: “Main Enterprise in the Advanced Manufacturing Industry Chain in Zhengzhou”, the Pharmaceutical Industry Chamber of Commerce of the All-China Federation of Industry and Commerce awarded the company the honor of “Anti-epidemic, Charity and Love”, Henan High-tech Enterprise, “National High-tech Industrialization Demonstration Project”, “Excellent Enterprise in Zhengzhou”, selected as “2022 Top 100 Chinese Pharmaceutical Industry Enterprises” by the China Traditional Chinese Medicine Association, and “2022 Top 100 Proprietary Chinese Medicine Enterprises” by the Henan Provincial People's Government, and “Key Leading Enterprise of Henan Province for Agricultural Industrialization (2024)” and “Anti-epidemic Supply and Protection Responsibility” by the China Non-Prescription Drug Association “Responsible enterprises”, “2022 Top 20 Science and Technology Innovation Enterprises” in the Zhengzhou High-tech Zone, etc.
Company Profile
Company Executives
- Name
- Position
- Salary
- hui yin
- Chairman, Directors, Chairman of the Strategic Decision Committee
- --
- jingliang li
- Vice Chairman, Directors, General Manager, Member of the Strategic Decision Committee
- 1.17M
- jianchao luo
- Directors, Member of the Strategic Decision Committee
- 849.60K
- siliang chen
- Directors, Audit Committee Member
- --
- jinge chen
- Directors, Member of the Remuneration and Assessment Committee
- --
- shiguang ma
- Directors, Nomination Committee Members
- --
- yumin liu
- Independent Directors, Audit Committee Member, Chairman of the Nomination Committee
- 100.00K
- xiaohua yin
- Independent Directors, Member of the Remuneration and Assessment Committee, Chairman of the Audit Committee
- 100.00K
- liang fang
- Independent Directors, Nomination Committee Members, Chairman of the Remuneration and Assessment Committee
- 100.00K
- nianyun li
- Board Secretary, Deputy General Manager
- 392.90K
- ting wu
- Securities Affairs Representative
- --
- zhixian zhang
- Chairman of the Supervisory Board, Auditors
- --
- yikun wang
- Auditors
- --
- lizhuang zhang
- Deputy General Manager
- 813.20K
- fengshan su
- Deputy General Manager
- 952.80K
- hailin zhao
- Executive Deputy General Manager, Head of Finance
- 900.70K
- kezhen wang
- Employee Supervisors
- --
No Data
